P618: SECOND-GENERATION CD19 TARGETING TRI-SPECIFIC KILLER ENGAGER DRIVES ROBUST NK CELL FUNCTION AGAINST B CELL MALIGNANCIES

• J. Miller,
• B. Kodal,
• P. Hinderlie,
• D. Vallera,
• G. Berk,
• V. Bachanova,
• M. Felices

Affiliations

J. Miller

1 Medicine

B. Kodal

1 Medicine

P. Hinderlie

1 Medicine

D. Vallera

2 Radiation Oncology, University of Minnesota, Minneapolis

G. Berk

3 GT Biopharma, Brisbane, United States of America

V. Bachanova

1 Medicine

M. Felices

1 Medicine